Keyphrases
Neonate
100%
Randomized Clinical Trial
100%
Acute Hypoxemic Respiratory Failure
100%
Exhaled Nitric Oxide
100%
Prostaglandin E1 (PGE1)
100%
PGI2
100%
Protocol Compliance
60%
Preterm Neonates
40%
High Dose
40%
Aerosolized
40%
Selective Pulmonary Vasodilator
40%
Placebo
20%
Prostaglandins
20%
Most Common Cause
20%
Number of Patients
20%
Novel Therapies
20%
Serious Adverse Events
20%
Randomized Controlled Trial
20%
Trial Registration
20%
Two-dose
20%
Arterial Blood Gas
20%
Late Preterm
20%
Oxygenation Index
20%
Sustained Improvement
20%
Persistent Pulmonary Hypertension of the Newborn
20%
Pilot RCT
20%
Pharmacy Protocol
20%
Non-enrolment
20%
Novel Study Designs
20%
Failure to Enroll
20%
Suboptimal Response
20%
Arterial Blood Gasses
20%
Medicine and Dentistry
Neonate
100%
Nitric Oxide
100%
Respiratory Failure
100%
Randomized Clinical Trials
100%
Randomized Controlled Trial
80%
Drug Megadose
40%
Neonatal Infant
40%
Peripheral Vasodilating Agent
40%
Primary Outcome
40%
Adverse Event
20%
Placebo
20%
Low Drug Dose
20%
Arterial Blood Gas
20%
Prostacyclin
20%
Persistent Fetal Circulation
20%
Prostaglandin E1
20%
Table Salt
20%
Neutron Capture Therapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide
100%
Randomized Clinical Trial
100%
Respiratory Failure
100%
Randomized Controlled Trial
80%
Peripheral Vasodilating Agent
40%
Adverse Event
20%
Placebo
20%
Prostacyclin
20%
Persistent Pulmonary Hypertension
20%
Prostaglandin E1
20%
Table Salt
20%
Biochemistry, Genetics and Molecular Biology
Nitric Oxide
100%
Randomized Clinical Trial
100%
Randomized Controlled Trial
80%
Drug Megadose
40%
Low Drug Dose
20%
Oxygenation
20%
Prostacyclin
20%
Arterial Blood Gas
20%
Prostaglandin E1
20%